Cisplatin and Obstruction - a phase IV clinical study of FDA data

Summary:

Obstruction is reported as a side effect among people who take Cisplatin (cisplatin), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Alimta, and have Non-small cell lung cancer stage iv.

The phase IV clinical study analyzes which people have Obstruction when taking Cisplatin. It is created by eHealthMe based on reports of 92,672 people who have side effects when taking Cisplatin from the FDA, and is updated regularly.

What is Cisplatin?

Cisplatin has active ingredients of cisplatin. It is often used in chemotherapy. eHealthMe is studying from 92,837 Cisplatin users. Check the latest studies of Cisplatin.

What is Obstruction?

Obstruction is found to be associated with 469 drugs and 644 conditions by eHealthMe. Check the latest studies of Obstruction.

On Aug, 04, 2026

92,672 people reported to have side effects when taking Cisplatin.
Among them, 34 people (0.04%) have Obstruction.

Among these 34 people:

How long have people been on Cisplatin when they have Obstruction? *

What is the gender of people who have Obstruction when taking Cisplatin? *

female: 31.25 %
male: 68.75 %

What is the age of people who have Obstruction when taking Cisplatin? *

What are other drugs people take besides Cisplatin? *

What are other side effects people have besides Obstruction? *

Pain: 7 people, 20.59%
Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 7 people, 20.59%
Acute Kidney Failure: 7 people, 20.59%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 6 people, 17.65%
Tumor Pain: 5 people, 14.71%
Failure To Thrive (inadequate weight gain and physical growth in children): 5 people, 14.71%
Haemoglobin Decreased: 4 people, 11.76%
Oral Intake Reduced: 4 people, 11.76%
Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking): 4 people, 11.76%
Dehydration (dryness resulting from the removal of water): 3 people, 8.82%

What are the existing conditions these people have? *

Non-Small Cell Lung Cancer Stage Iv: 8 people, 23.53%
Chest Pain: 4 people, 11.76%
Oesophageal Carcinoma (cancer tumour of oesophagus): 2 people, 5.88%
Non-Small Cell Lung Cancer Metastatic (type of epithelial lung cancer spreads to other parts): 2 people, 5.88%
Analgesia: 2 people, 5.88%
Small Cell Lung Cancer Stage Unspecified (lung cancer in unknown stage): 1 person, 2.94%
Small Cell Lung Cancer Metastatic (lung cancer spreads to other body parts): 1 person, 2.94%
Small Cell Lung Cancer Extensive Stage (small cell lung cancer that has spread (metastasized) to other regions of the body such as another lobe of the lung or the brain): 1 person, 2.94%
Pleural Mesothelioma Malignant (cancer of the pleura, or the membrane that lines the lungs): 1 person, 2.94%
Pancreatic Carcinoma Metastatic (pancreatic cancer- metastatic): 1 person, 2.94%

* Approximation only. Some reports may have incomplete information.

Do you take Cisplatin and have Obstruction?

- Check whether Obstruction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cisplatin:

Cisplatin (92,837 reports)

Obstruction treatments and more:

Obstruction (4,654 reports)

Browse all side effects of Cisplatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Obstruction:

Obstruction (469 drugs)

Browse all the conditions that are associated with Obstruction:

Obstruction (644 conditions)

Related publications that referenced our studies

Schlumbrecht MP, Hehr K, "Cisplatin-induced bradycardia and the importance of the QT interval", Journal of Oncology Pharmacy Practice, 2015 Jan .
Schlumbrecht MP, Hehr K, "Cisplatin-induced bradycardia and the importance of the QT interval", Journal of Oncology Pharmacy Practice, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on cisplatin (the active ingredients of Cisplatin) and Cisplatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.